Metlife, Inc. (NYSE: MET) has recently announced an unsolicited mini-tender offer by Potemkin Limited to purchase up to 10,000 shares of Metlife, Inc. common stock from Metlife shareholders. However, the offer price of $53.00 per share is approximately 34.42 percent lower than the $80.82 closing price of Metlife common stock on September 12, 2025.
It's important to note that this offer is for approximately 0.00002 percent of Metlife’s shares of common stock outstanding as of August 31, 2025. Metlife does not endorse Potemkin’s unsolicited mini-tender offer and recommends that shareholders do not tender their shares in response to Potemkin’s offer because the offer is at a price that is significantly below the current market value of Metlife’s common stock.
Metlife urges investors to obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to Potemkin’s offer. Additionally, the offer is currently scheduled to expire on Tuesday, October 7, 2025, at 5 p.m. Eastern Time.
It's worth noting that Potemkin has made similar mini-tender offers for shares of other companies, and mini-tender offers, such as this one, seek to acquire less than five percent of a company’s shares outstanding, thereby avoiding many disclosure and procedural requirements of the SEC.
Metlife encourages shareholders who have not responded to Potemkin’s offer to take no action and also encourages brokers and dealers, as well as other market participants, to review the SEC’s letter regarding broker-dealer mini-tender offer dissemination and disclosure.
Following these announcements, the company's shares moved -0.62%, and are now trading at a price of $80.32. Check out the company's full 8-K submission here.
